271 related articles for article (PubMed ID: 36598437)
1. Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy.
Barcellos-Hoff MH; Gulley JL
Clin Cancer Res; 2023 Jun; 29(11):2025-2033. PubMed ID: 36598437
[TBL] [Abstract][Full Text] [Related]
2. The radiobiology of TGFβ.
Barcellos-Hoff MH
Semin Cancer Biol; 2022 Nov; 86(Pt 3):857-867. PubMed ID: 35122974
[TBL] [Abstract][Full Text] [Related]
3. Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.
Liu Q; Palomero L; Moore J; Guix I; Espín R; Aytés A; Mao JH; Paulovich AG; Whiteaker JR; Ivey RG; Iliakis G; Luo D; Chalmers AJ; Murnane J; Pujana MA; Barcellos-Hoff MH
Sci Transl Med; 2021 Feb; 13(580):. PubMed ID: 33568520
[TBL] [Abstract][Full Text] [Related]
4. TGFβ Signaling in the Tumor Microenvironment.
Goulet CR; Pouliot F
Adv Exp Med Biol; 2021; 1270():89-105. PubMed ID: 33123995
[TBL] [Abstract][Full Text] [Related]
5. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy.
Chen J; Ding ZY; Li S; Liu S; Xiao C; Li Z; Zhang BX; Chen XP; Yang X
Theranostics; 2021; 11(3):1345-1363. PubMed ID: 33391538
[TBL] [Abstract][Full Text] [Related]
6. Exploiting Canonical TGFβ Signaling in Cancer Treatment.
Liu Q; Chen G; Moore J; Guix I; Placantonakis D; Barcellos-Hoff MH
Mol Cancer Ther; 2022 Jan; 21(1):16-24. PubMed ID: 34670783
[TBL] [Abstract][Full Text] [Related]
7. TGFβ biology in cancer progression and immunotherapy.
Derynck R; Turley SJ; Akhurst RJ
Nat Rev Clin Oncol; 2021 Jan; 18(1):9-34. PubMed ID: 32710082
[TBL] [Abstract][Full Text] [Related]
8. Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.
Du S; Barcellos-Hoff MH
Semin Radiat Oncol; 2013 Oct; 23(4):242-51. PubMed ID: 24012338
[TBL] [Abstract][Full Text] [Related]
9. Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.
Guix I; Liu Q; Pujana MA; Ha P; Piulats J; Linares I; Guedea F; Mao JH; Lazar A; Chapman J; Yom SS; Ashworth A; Barcellos-Hoff MH
Clin Cancer Res; 2022 Apr; 28(7):1372-1382. PubMed ID: 35022323
[TBL] [Abstract][Full Text] [Related]
10. New rationales for using TGFbeta inhibitors in radiotherapy.
Andarawewa KL; Paupert J; Pal A; Barcellos-Hoff MH
Int J Radiat Biol; 2007; 83(11-12):803-11. PubMed ID: 18058368
[TBL] [Abstract][Full Text] [Related]
11. TGFβ and the Tumor Microenvironment in Colorectal Cancer.
Waldner MJ; Neurath MF
Cells; 2023 Apr; 12(8):. PubMed ID: 37190048
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR; Alexe G; Reiss M
Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
[TBL] [Abstract][Full Text] [Related]
13. Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining.
Liu Q; Ma L; Jones T; Palomero L; Pujana MA; Martinez-Ruiz H; Ha PK; Murnane J; Cuartas I; Seoane J; Baumann M; Linge A; Barcellos-Hoff MH
Clin Cancer Res; 2018 Dec; 24(23):6001-6014. PubMed ID: 30087144
[TBL] [Abstract][Full Text] [Related]
14. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of therapies targeting TGFβ: current knowledge and future perspectives.
Ciardiello D; Elez E; Tabernero J; Seoane J
Ann Oncol; 2020 Oct; 31(10):1336-1349. PubMed ID: 32710930
[TBL] [Abstract][Full Text] [Related]
16. Overcoming TGFβ-mediated immune evasion in cancer.
Tauriello DVF; Sancho E; Batlle E
Nat Rev Cancer; 2022 Jan; 22(1):25-44. PubMed ID: 34671117
[TBL] [Abstract][Full Text] [Related]
17. Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1.
Quach HT; Hou Z; Bellis RY; Saini JK; Amador-Molina A; Adusumilli PS; Xiong Y
Expert Opin Investig Drugs; 2022 Nov; 31(11):1187-1202. PubMed ID: 36448335
[TBL] [Abstract][Full Text] [Related]
18. Targeting the TGFβ pathway for cancer therapy.
Neuzillet C; Tijeras-Raballand A; Cohen R; Cros J; Faivre S; Raymond E; de Gramont A
Pharmacol Ther; 2015 Mar; 147():22-31. PubMed ID: 25444759
[TBL] [Abstract][Full Text] [Related]
19. Targeting TGFβ signal transduction for cancer therapy.
Liu S; Ren J; Ten Dijke P
Signal Transduct Target Ther; 2021 Jan; 6(1):8. PubMed ID: 33414388
[TBL] [Abstract][Full Text] [Related]
20. TGFβ Signaling in Photoaging and UV-Induced Skin Cancer.
Ke Y; Wang XJ
J Invest Dermatol; 2021 Apr; 141(4S):1104-1110. PubMed ID: 33358021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
